07 Jan 2001

codi OPT® (codi OPT® Tabletten) - Deutschland

codi OPT® Description, Presentation and Dosage

codi OPT® Description

codi OPT® Drug Class Description

Morphin u. Derivate

codi OPT® Drug Description

1 Tbl. enth.: Codeinphosphat ½H2O 76,82 mg (entspr. 56,53 mg Codeinbase).

codi OPT® Generic Name

codi OPT® Tabletten

codi OPT® Presentation

codi OPT® Presentation

codi OPT®

codi OPT® Manufacturer

Optimed

Related Learning Zones

CSU Knowledge Centre and CME

CSU Knowledge Centre and CME

This Knowledge Centre is intended for allergists, immunologists, dermatologists and other healthcare professionals involved in the treatment and management of Chronic Spontaneous Urticaria (CSU). In the Knowledge Centre, you will find a disease overview, symposium highlights platform, video channel and additional resources including an events calendar and useful external links. This resource has been given a whole new look and feel, intended to improve accessibility and visual appeal. Recent content additions include a frequently asked questions section, case studies from urticaria experts Professor Christian Vestergaard and Professor Torsten Zuberbier and information on the TARGET My Hives app.

Hyperammonaemia Knowledge Centre

Hyperammonaemia Knowledge Centre

The Hyperammonaemia Knowledge Centre has been developed to raise awareness of this rare yet potentially deadly condition. Using this resource, healthcare professionals are encouraged to recognise the signs and symptoms of hyperammonaemia and begin the correct treatment immediately.

codi OPT® Dosage

codi OPT® Adult Dosage

Crospovidon, Lactose 1H2O, Magnesiumstearat, Povidon.

codi OPT® Precautions, Reactions and Contraindications

codi OPT® Special Precautions

codi OPT® Special Precautions

C 85 a-c

codi OPT® Adverse Reactions

codi OPT® Adverse Reactions

C 85

Related Drugs - Pain Management

Back to top